These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Formulary Coverage of Brand-Name Adalimumab and Biosimilars Across Medicare Part D Plans.
    Author: Klebanoff MJ, Li P, Lin JK, Doshi JA.
    Journal: JAMA; 2024 Jul 02; 332(1):74-76. PubMed ID: 38842823.
    Abstract:
    This study examines formulary coverage of brand-name adalimumab and biosimilars across Medicare Part D plans.
    [Abstract] [Full Text] [Related] [New Search]